Scientific programme

Scientific programme

Meet up with your international colleagues in Transfusion Medicine at this inspiring Congress! Our scientific secretary Ellen van der Schoot and the chairwoman of the ISBT Academy Erica Wood, together with members of the Local Organising committee have assembled an inspiring, educative scientific programme comprising of a wide variety of presentations on innovative research, but also back-to-basic talks in the Academy sessions. The scientific programme will touch upon different aspects of blood transfusion relevant to the region and will provide you and your colleagues with important knowledge.

The current scientific programme only includes the invited speakers. Authors of abstracts chosen for oral presentation will be added following the scientific review meeting which will take place at the end of August.

PROGRAMME PER DAY

08.30 - 09.1Opening Ceremony
09.15 - 10.00Plenary Session I: TRALI
09.15 - 10.00How different models help us understand TRALI
L. Fung (Australia)
10.00 - 10.30Coffee Break
10.30 - 12.00Scientific: Haemovigilance
10.30 - 11.00The journey toward safer and optimized blood service in China
Zhong Liu (China)
11.00 - 12.00Selected abstracts
10.30 - 12.00Academy: Young Donors
10.30 - 11.00Young donors: getting their attention and keeping them engaged
S. L. Li (Taiwan)
11.00 - 11.30What are the special issues for young donors?
H. H. Tan (Singapore)
11.30 - 12.00Panel and audience discussion
12.00 - 13.30Lunch Break
13.30 - 15.00Best Abstracts Session
13.30 - 15.00Selected abstracts
13.30 - 15.00Novel Technologies
13.30 - 14.00Application of kodecytes in immunohematology
S. Henry (New Zealand)
14.00 - 14.30A dye-assisted paper-based point-of-care assay for fast and reliable blood grouping
L. Yang (China)
14.30 - 15.00DNA of erythroid origin presence in human plasma
L. Jacky (Hong Kong)
15.00 - 15.30Coffee break
15.30 - 17.00Scientific: Massive Transfusion
15.30 - 16.00Haemorrhage protocols 
S. Allard (UK)
16.00 - 17.00Selected abstracts
15.30 - 17.00Academy: Transfusion Leadership
15.30 - 16.00Transfusion leadership in the hospital
M. Cole-Sinclair (Australia)
16.00 - 16.30Blood centre leadership
Y. M. Zhu (China)
16.30 - 17.00Questions and answers on transfusion leadership - open forum
17.00 - 18.00Poster session
08.30 - 10.00Plenary Session II: Transfusion support for haemoglobinopathies in the region
08.30 - 09.00Stem cell therapies for thalassemia
S. Hongeng (Thailand)
09.00 - 09.30Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients:  the THETIS study
Y. R. Lai (China)
09.30 - 10.00Matched sibling donor hematopoietic stem cell transplantation for thalassemia
S. Issaragrisil (Thailand)
10.00 - 10.30Coffee break
10.30 - 12.00 Scientific: Hepatitis
10.30 - 11.00 Invited Speaker
11.00 - 12.00Selected abstracts
10.30 - 12.00Academy: Transfusion education for nurses and transfusion practitioners
10.30 - 11.00Transfusion medicine education in China
C. Li (China)
11.00 - 11.30Transfusion medicine education for blood centre staff
S. Kwon (Korea)
11.30 - 12.00Transfusion medicine education for nurses and transfusion practitioners
L. Biebly (Australia)
12.00 - 13.30Lunch Break
13.30 - 15.00Scientific: Cellular Therapies
13.30 - 14.00Culturing red blood cells
E. J. Baek (South Korea)
14.00 - 15.00Selected abstracts
13.30 - 15.00Academy: Quality Management in the Laboratory
13.30 - 14.00Invited Speaker
14.00 - 14.30Preparing your blood centre for accreditation
C.K. Lee (Hong Kong)
14.30 - 15.00Invited Speaker
15.00 - 15.30Coffee break
15.30 - 17.00Scientific: Red cell genetics
15.30 - 16.00Next-generation sequencing with automatic analysis is credible to predict blood group genotype
and to solve complex cases with novel allele findings
P. C. Wu (Taiwan)
16.00 - 17.00Selected abstracts
15.30 - 17.00Academy: Haemovigilance
15.30 - 16.00Experience of haemovigilance in Japan
M. Satake (Japan)
16.00 - 16.15Haemovigilance in China: Shanghai experience
D. XIe (China)
16.15 - 16.30Haemovigilance in China: Jiangsu Province experience
W. Liang (China)
16.30 - 16.45Donor haemovigilance in Singapore
H. H. Tan (Singapore)
16.45 - 17.00Invited Speaker
08.30 - 10.00Plenary Session III: Platelets
08.30 - 09.00Clinical impact of CD36 antigen/antibodies in Asian population
X. Xiuzhang (China)
09.00 - 09.30Multifaceted regenerative lives of expired platelets
T. Burnouf (Taiwan)
09.30 - 10.00Clinical trial on frozen platelets 
M. Reade (Australia)
10.00 - 10.30Coffee break
10.30 - 12.00 Scientific: TTID screening
10.30 - 11.00Blood screening strategy in Indonesia
Y. Soedermono (Indonesia)
11.00 - 12.00 Selected abstracts
10.30 - 12.00Academy: The transfusion team: the role of the TP
10.30 - 11.00The role of the transfusion practitioner in the multidisciplinary team
L. Bielby (Australia)
11.00 - 11.30The transfusion support nurse role at KK Hospital in Singapore
X. Zhong (Singapore)
11.30 - 12.00Discussion: Challenges and opportunites for transfusion practitioners in the region
12.00 - 13.30Lunch Break
13.30 - 15.00Scientific: Donor management
13.30 - 14.00Managing blood donation in emergency situations
M. Rajkavnikar (Nepal)
14.00 - 15.00Selected abstracts
13.30 - 15.00Academy: The role of molecular testing in the transfusion laboratory 
13.30 - 13.45Introduction
J. Storry (Sweden)
13.45 - 14.15Basic aspects, applications and platforms currently available for molecular blood grouping
of donor and patient populations
V. Sekaran Nadarajan (Malaysia)
14.15 - 14.45Practicalities and pitfalls in the molecular lab
Y. Ji (China)
14.45 - 15.00Panel discussion
15.00 - 15.30Coffee break
15.30 - 17.00Plenary Session IV: TTID
15.30 - 16.00Pathogen reduction technology
R. Dodd (USA)
16.00 - 16.30Y. S. Leo (Singapore)
16.30 - 17.00High prevalence of HBV infection remains in young Chinese blood donors
Y. Fu (China)
17.00Closing Ceremony